These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
795 related articles for article (PubMed ID: 19762981)
1. Effects of IgY against Candida albicans and Candida spp. Adherence and Biofilm Formation. Fujibayashi T; Nakamura M; Tominaga A; Satoh N; Kawarai T; Narisawa N; Shinozuka O; Watanabe H; Yamazaki T; Senpuku H Jpn J Infect Dis; 2009 Sep; 62(5):337-42. PubMed ID: 19762981 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). Ibrahim el-SM; Rahman AK; Isoda R; Umeda K; Van Sa N; Kodama Y Vaccine; 2008 Apr; 26(17):2073-80. PubMed ID: 18375022 [TBL] [Abstract][Full Text] [Related]
3. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687 [TBL] [Abstract][Full Text] [Related]
4. AmBisome and Amphotericin B inhibit the initial adherence of Candida albicans to human epithelial cell lines, but do not cause yeast detachment. Dorocka-Bobkowska B; Düzgüneş N; Konopka K Med Sci Monit; 2009 Sep; 15(9):BR262-9. PubMed ID: 19721394 [TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells. Johann S; Soldi C; Lyon JP; Pizzolatti MG; Resende MA Lett Appl Microbiol; 2007 Aug; 45(2):148-53. PubMed ID: 17651210 [TBL] [Abstract][Full Text] [Related]
6. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Braga PC; Culici M; Alfieri M; Dal Sasso M Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858 [TBL] [Abstract][Full Text] [Related]
8. In vitro synergistic effect of farnesol and human gingival cells against Candida albicans. Saidi S; Luitaud C; Rouabhia M Yeast; 2006 Jul; 23(9):673-87. PubMed ID: 16845684 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of baicalein against Candida albicans biofilms. Cao Y; Dai B; Wang Y; Huang S; Xu Y; Cao Y; Gao P; Zhu Z; Jiang Y Int J Antimicrob Agents; 2008 Jul; 32(1):73-7. PubMed ID: 18374543 [TBL] [Abstract][Full Text] [Related]
10. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents. Harrison JJ; Turner RJ; Ceri H FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429 [TBL] [Abstract][Full Text] [Related]
11. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment. Borecká-Melkusová S; Bujdáková H Can J Microbiol; 2008 Sep; 54(9):718-24. PubMed ID: 18772934 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775 [TBL] [Abstract][Full Text] [Related]
13. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. Bruzual I; Riggle P; Hadley S; Kumamoto CA J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564 [TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of gallic acid against Candida albicans biofilms]. Wang C; Cheng H; Guan Y; Wang Y; Yun Y Zhongguo Zhong Yao Za Zhi; 2009 May; 34(9):1137-40. PubMed ID: 19685753 [TBL] [Abstract][Full Text] [Related]